Vikram Chaudhery
Independent Director at Nureca
San Francisco, California
Overview
Work Experience
Founder, President & COO
2020 - Current
General Inception is an institutional co-founder for science-based companies.
Partner
2019
Genoa Ventures is a venture capital firm that invests in early-stage life sciences technology companies.
Board Member
2021
SimBioSys is developing a Computational Microscope to provide new insight into the behavior of cancers.
Raised $15,000,000.00 from Heritage Group, Mayo Clinic, AV8 Ventures, Genoa Ventures and Northpond Ventures.
Board Member
2022
Epitel is empowering clinicians, patients, and caregivers who live with or care for neurological disorders with wearables and powerful AI.
Raised $20,400,000.00 from OSF Ventures, Dexcom Ventures, MedMountain Ventures, Genoa Ventures, Catalyst Health Ventures, SLC Angels and Wavemaker 360.
Board Member
2021
Board Observer
2020 - 2021
BRAINBox provides objective evidence of injury and prediction of patient recovery.
Raised $39,502,735.00 from Genoa Ventures.
Independent Director
2021
Investor
2021
Board Observer
2019 - 2023
Head of Life Sciences
2017 - 2019
Formulate acquisition strategy to build a new Life Sciences division for Lam Research, a leader in the semiconductor tools market. ► Led evaluation of new business opportunities for Lam in the life sciences industry. ++Led Lam's Life Sciences strategy in emerging businesses, corporate development ++Led all strategic planning activities across Genomics, Proteomics, Bioinformatics, Sample prep and Synthetic Biology: Market evaluation, segmentation, customer unmet needs, competitive analysis, technology diligence and strategic road mapping. ► Led all deal sourcing and deal structuring activities for investments, joint development agreements and acquisitions in life sciences ++Led all Life Sciences venture investments including Lam Antheia, Mission Bio, Ominiome ++Led the sourcing and diligence for joint development partnership with Nanostring ► Oversaw all investments and partnerships post close ++Member of joint-steering committee for partnership with Nanostring ++Primary business lead for all partnerships and investments ++Managed investment performance and fielded all support needs from engineering, nanofabrication and operations. ► Built scientific and commercial advisory boards and oversaw all consultancy partnerships ► Built and maintained relationships between venture, private organizations and academic institutions across the US and European innovation ecosystem
Lam Research supplies wafer fabrication equipment and services to the worldwide semiconductor industry.
Engagement Manager
2013 - 2017
Management consulting to myriad of clients from Fortune 500 to startup. Led teams of industry experts, client executives and consultants to solve critical business problems for Fortune 500 Life Sciences corporations and leading biotechnology startup companies across the world. A handful of examples : ► Growth strategy for a Fortune 500 company ++Led in depth market analysis across Life Sciences ++ Led identification and diligence of minority investments, partnerships and acquisitions ++ Developed a portfolio based risk analysis approach for assessing assessing execution options ► Growth strategy for a med device company ++ Delivered sales strategies and launched pilot initiatives for 50+% growth two major assets into clinical space ► Growth and R&D strategy for a startup biotech ++ Streamlined a R&D strategy for clinical trials ++ Developed a financial forecasting tool for risked based analysis to inform portfolio expansion ► Due Diligence for major merger for a major pharma company ++ Pre-merger diligence and post merger synergy and transformation focused on operations strategy and supplier collaboration efforts ► Due diligence activity for healthcare private equity ++ Led Synergy assessment, deal structuring ++ Developed post acquisition transformation plan ► Comprehensive strategic sourcing transformation effort for a major Life Sciences company ++ Led restructuring of sourcing strategy for pharmacy, consumer medical devices and medical diagnostic equipment etc. ► Due-diligence and post merger integration in life sciences ++ Evaluated pre-merger synergy opportunities ++ Developed post-merger operating model, combined sourcing strategy, optimizing internal and external manufacturing and quality organization footprint
McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity